baber/WOPTO huggingface dataset:
Patent AU-5461300-A (AU)
Title: Devices and methods for enhanced microneedle penetration of biological barriers
Inventor: PRAUSNITZ MARK R
IPC: A61B5/00
Filed: 2000-06-02
Abstract: Microneedle devices are provided for delivery of drugs across biological tissue and for controlled sampling of biological fluids in a minimally-invasive, painless, and convenient manner. The devices permit 1) drug delivery at clinically relevant rates across or into skin or other tissue barriers, and/or 2) in vivo sensing or withdrawal of biological fluids from the body, particularly from or through the skin or other tissue barriers. Drug delivery devices preferably include a plurality of hollow microneedles attached to or integrated into a substrate, and at least one reservoir (containing drug) selectably in communication with the microneedles, wherein the amount of drug to be delivered can be selectively altered. Withdrawal or sensing microneedle devices preferably include microneedles attached to or integrated into a substrate, and at least one collection chamber and/or sensor in communication with the microneedles.
Patent AU-5482399-A (AU)
Title: Orally disintegrable tablet forming a viscous slurry
Inventor: SIEBERT JOHN M
IPC: A61K9/20
Filed: 1999-08-12
Abstract: A dosage form which rapidly disintegrates in the mouth and forms a viscous slurry of either microcapsules or a powder is described. The rapidly disintegrating dosage form is meant for direct oral administration by placing a tablet or capsule in the mouth of a patient. Upon disintegration, a viscosity of the resulting slurry increases so as to form an organoleptically pleasant viscous material which retards the spread of insoluble materials including the drug.
Patent AU-5629790-A (AU)
Title: Aqueous folinate solution stable at refrigerator temperature, as well as process for its preparation
IPC: A61K31/519
Filed: 1990-06-05
Abstract: An aqueous folinate solution stable at refrigerator temperature is provided which contains folinate ions, complexed calcium ions, and if desired free calcium ions in a total amount of more than 12 mg/ml, as well as anions of a complexing agent for calcium. This solution is prepared by incorporating the complexing agent therein.
Patent AU-5679800-A (AU)
Title: Lock armature
Inventor: BELTZ ERIK
IPC: E05C9/18
Filed: 2000-06-09
Abstract: The invention relates to a lock armature between a wing (1) and a stationary frame (2) of a window, a door or the like. The wing (1) and the frame (2) can be fixed in relation to each other by means of locking elements in the form of bolt protuberances (9) and a locking component (10). The bolt protuberances (9) and the locking component (10) can be engaged with one another by a relative movement. According to the invention, the bolt protuberance (9) engages behind the locking component (10). The aim of the invention is to avoid a direct engagement and the thereby resulting surface damage at the bolt protuberance (9) or the locking component (10). To this end, the active areas that extend crosswise and pertain to the locking device (10) and the bolt protuberance (9) are at least partially separated from each other in a direction that is crosswise in relation to the relative movement and by means of a defined contact edge.
Patent AU-5690590-A (AU)
Title: Explosive detection screening system
Inventor: CORRIGAN COLIN D
IPC: G01N30/02
Filed: 1990-06-07
Abstract: An explosive detection screening system used for the detection of explosives and other controlled substances such as drugs or narcotics. The screening system detects the vapor and/or particulate emissions from the aforementioned substances and reports that they are present on an individual or object and the concentration of each substance detected. The screening system comprises a sampling chamber for the collection of the vapor and/or particulate emissions, a concentration and analyzing means for the purification of the collected vapor and/or particulate emissions and subsequent detailed chemical analysis of said emissions, and a control and data processing system for the control of the overall system.
Patent AU-5740790-A (AU)
Title: Vascular access system for extracorporeal treatment of blood
Inventor: LOITERMAN DAVID A
IPC: A61M1/14
Filed: 1990-05-11
Abstract: Disclosed are implantable, vascular access ports and vascular access systems including such ports. These ports include a biocompatible housing having at least one internal open-faced chamber extending along a reference axis, and defined by a concave sidewall and a bottom wall. The concave sidewall is concave in the direction of the axis and forms a lateral sidewall for the chamber. The port further includes a septum of biocompatible, self-resealing, penetrable material affixed to the housing and spanning the periphery of the open face of the chamber. A cannula is attached at a first end to the housing and extends laterally from that end. Its second end is adapted to receive a catheter. The cannula further includes internal walls defining a channel extending from the first end, along a channel axis from a point on the lateral boundary of, and in communication with, the chamber to the second end.
Patent AU-5875394-A (AU)
Title: Device for producing separator pockets for electrical accumulator plates
Inventor: FREY HELMUT
IPC: H01M50/469
Filed: 1994-01-21
Abstract: PCT No. PCT/AT94/00004 Sec. 371 Date Apr. 8, 1996 Sec. 102(e) Date Apr. 8, 1996 PCT Filed Jan. 21, 1994 PCT Pub. No. WO94/17984 PCT Pub. Date Aug. 18, 1994Apparatus for making separator envelopes for electrical battery plates having a device for folding an ultrasonically weldable polymeric web around individual battery plates and a device for feeding filled separator envelopes to ultrasonic welding devices, The feed device being provided with two endless synchronously driven feed belts (4, 8) above and below a horizontal feed plane (H) for the separator envelopes (S) as well as symmetrically relative to a longitudinal center plane of the apparatus, which feed belts, with their loops extending parallel to the feed plane, together engage lateral portions of the separator envelopes and which continuously pull the superposed lateral margins of the separator envelopes protruding beyond the feed belts through the ultrasonic welding device.
Patent AU-6087294-A (AU)
Title: Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
Inventor: DUGAR SUNDEEP
IPC: C07D205/12
Filed: 1994-01-19
Abstract: Novel compounds of the formula   <IMAGE>   or a pharmaceutically acceptable salt thereof, wherein: R1 is   <IMAGE>    <IMAGE>   R2 and R3 are independently selected from -CH2-, -CH(lower alkyl)-, -C(di-lower alkyl)-, -CH=CH- and -C(lower alkyl)=CH-; or R1 with R2, or R1 with R3, form -CH=CH- or -CH=C(lower alkyl)-; u and v are independently 0-3, provided both are not zero; R4 is B-(CH2)mC(O)-; m is 0-5; B-(CH2)q-; q is 0-6; B-(CH2)e-Z-(CH2)r; Z is -O-, -C(O)-, phenylene, -N(R8)- or -S(O)0-2-, e and r is 0-5; the sum of e and r is 0-6; B-(C2-C6 alkenylene)-; B'-(C4-C6 alkadienylene)-; B-(CH2)t-Z-(C2-C6 alkenylene)-; t is 0-3; the sum of t and the number of carbon atoms in the alkenylene chain is 2-6; B-(CH2)f-V-(CH2)g-; V is cycloalkylene, f is 1-5, g is 0-5; the sum of f and g is 1-6; B-(CH2)t-V-(C2-C6 alkenylene)- or B'-(C2-C6 alkenylene)-V-(CH2)t-; the sum of t and the number of carbon atoms in the alkenylene chain is 2-6, B-(CH2)a-Z-(CH2)b-V-(CH2)d-; a, b and d are 0-6; the sum of a, b and d is 0-6; T-(CH2)s-; T is cycloalkyl, s is 0-6; or R1 and R4 together form   <IMAGE>   B is optionally-substituted phenyl, indanyl, indenyl, naphthyl, tetrahydronaphthyl or optionally substituted-heteroaryl; and R20 and R21 are independently optionally-substituted phenyl, optionally-substituted naphthyl, indanyl, indenyl, tetrahydronaphthyl, benzodioxolyl, optionally-substituted heteroaryl, optionally-substituted benzofused heteroaryl or cyclopropyl, pharmaceutical compositions, the use as hypocholesterolemic agents, processes for preparing, and the use in combination with cholesterol biosynthesis inhibitors to treat or prevent athersclerosis.
Patent AU-6101898-A (AU)
Title: Ouabain immunoassay and kit and ouabain labeled with i125 or fluorescent label
Inventor: LEPPALUOTO PEKKA JUHANI
IPC: G01N33/94
Filed: 1998-02-25
Abstract: The invention deals with the use of a reactive compound in immunological analyses. The compound is ouabain or its analog to which another compound, labeled by radioiodine or by a fluorogen, is coupled. The invention covers also the method to measure ouabain or its analog in plasma to diagnose cardiovascular and endocrine diseases and other harmful conditions.
Patent AU-6161080-A (AU)
Title: Box shaped packing for dental care means
Inventor: HEITLINGER P
IPC: A46B17/00
Filed: 1980-08-21
Abstract: The present invention provides a case-like container having plastic walls, for keeping items used in dental hygiene in which a substantial portion of the container is in the form of a beaker around which there is disposed a folded toothbrush within walls that can at least be partially torn off.
Patent AU-6220499-A (AU)
Title: Jellybean knee joint (improvement)
Inventor: WALKER PETER STANLEY
IPC: A61F2/38
Filed: 1999-10-14
Abstract: A total replacement prosthesis (TKR) is described comprising a femoral component (2) having a pair of condylar-bearing surfaces and a tibial component (4) having dished bearing surfaces and interior (A) and posterior (P) sides, wherein the condylar-bearing surfaces and tibial-bearing surfaces are so shaped that when viewed as a series of transverse slices extending transversely to the anterior-posterior direction, contact points (L1, L2, L3, M1, M2, M3) between the bearing surfaces are displaced posteriorly with flexion and anteriorly with extension or vice versa, and each contact point constitutes the lowest point on the tibial bearing surface at a given angle of flexion (Alpha, Beta).
Patent AU-6370596-A (AU)
Title: Heat treatment of carbon materials
Inventor: LYNUM STEINAR
IPC: C09C1/56
Filed: 1996-07-05
Abstract: The invention concerns a method for heat treatment of carbon materials and especially carbon black in a plasma process for increased order in the nanostructure, i.e. an increased degree of graphitization in the carbon black particles. The process consists in an upgrading of commercial carbon black qualities and non-graphitic carbon materials. The heat treatment is conducted in a plasma zone where the residence time and power supplied are controlled in order to ensure that the carbon material does not sublimate. Thus the carbon which is supplied to the plasma zone is prevented from being transformed and reformed into a new product.
Patent AU-6526790-A (AU)
Title: Device for programmed recording by recognition of reference signals
Inventor: MICHERON FRANCOIS
IPC: G11B15/02
Filed: 1990-09-25
Abstract: The invention relates to a device for the selective recording of audio-visual sequences, actuated precisely at the times of beginning or end of the recorded audio-visual sequence. According to the invention, the piloting device is comprised of means (11) for image information reduction of at least one reference image belonging to said sequence to be said sequence to be recorded, a memory (12) for storing said reduced reference image information, means (14) for comparing said stored reduced information with reduced image information taken from said set of image sequences and means (18) for controlling said recording apparatus, activated by said comparison means upon recognition of an image similar to said reference image within the set of image sequences.
Patent AU-6560686-A (AU)
Title: Improved process for preparing 5-(2,5-dimethylphenoxy)- 2,2-dimethylpentanoic acid
Inventor: KEARNEY FRANCIS R
IPC: C07C51/367
Filed: 1986-11-24
Abstract: An improved two-step process for preparing 5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid (gemfibrozil) which regularly affords gembibrozil in overall yields in excess of 80% comprises reacting an alkali metal salt of a lower alkyl ester of 2-methylpropanoic acid with 1,3-dibromopropane or 1-bromo-3-chloropropane in a polar aprotic solvent such as tetrahydrofuran, and then reacting the intermediate thus formed with an alkali metal salt of 2,5-dimethylphenol in a mixed toluene/dimethylsulfoxide solvent system.
Patent AU-6663886-A (AU)
Title: Crosslinkable elastomeric compositions
Inventor: WONG PUI KWAN
IPC: C08K5/01
Filed: 1986-12-17
Abstract: Polymeric compositions which may be readily cross-linked at temperatures above about 200  DEG C comprise an elastomeric polymer possessing olefinic unsaturation and an effective amount of a benzocyclobutene derivative of the general formula <CHEM>  where "X" is selected from the group consisting of <CHEM>  and -(R-)- where "R" is an alkylene group of 1 to 10 carbon atoms. Cured compositions are also claimed.
Patent AU-6964587-A (AU)
Title: Catalyst compositions
Inventor: VAN BROEKHOVEN JOHANNES ADRIAN
IPC: C08G67/02
Filed: 1987-03-03
Abstract: Novel catalyst compositions, characterized in that they are based upon     a) a palladium compound, b) an acid with a pKa of less than 2, provided that the acid is not a hydrohalogenic acid, c) a bidentate ligand of the general formula R<1>R<2>-M-R-M-R<3>R<4>, wherein M represents phosphorus, arsenic or antimony, R<1>, R<2>, R<3> and R<4> represent hydrocarbyl groups which may or may not be substituted with polar groups and R represents a bivalent organic bridging group having at least two carbon atoms in the bridge, and   d) a quinone.
Patent AU-6994096-A (AU)
Title: Method for the preparation of cation exchange membranes doped with insoluble metal salts
Inventor: AGOSTINO VINCENT F D
IPC: H01M8/02
Filed: 1996-09-19
Abstract: A method of preparing a modified cation exchange membrane in which a sulfide of silver, tungsten, molybdenum or a mixture thereof is deposited within the polymer matrix, which method comprises the steps of: i) forming within the polymer matrix of the membrane a complex of silver, tungsten, molybdenum or a mixture thereof with a water soluble compound containing an -SH group; and ii) converting the complex formed in step (i) into the insoluble sulfide of silver, tungsten, molybdenum or a mixture thereof.
Patent AU-7312881-A (AU)
Title: Countercurrent recrystallisation
Inventor: THIJSSEN H A C
IPC: B01D9/00
Filed: 1981-07-20
Abstract: This invention concerns an improved process for separating one crystallizable component from a liquid containing a plurality of components, which comprises passing a stream of said liquid successively through at least part of a series of zones of successively lower temperatures including the zone of lowest temperature, so as to induce the formation of crystals of said one component in each of said zones, passing the crystals formed in each of said zones in a direction countercurrent to the direction of the stream of liquid through at least part of said zones, including the zone of highest temperature, separating the crystals present in the zone of highest temperature from their mother liquor and recovering at least part of these crystals, seperating the crystals in the zone of lowest temperature from their mother liquor and recovering that mother liquor, and recirculating part of said crystals present in one zone, from that zone to a zone of lower temperature.This invention also concerns an apparatus tor carrying out the process.
Patent AU-7439996-A (AU)
Title: Novel uses of mammalian ctla-8 and related reagents
Inventor: BANCHEREAU JACQUES
IPC: A61P31/04
Filed: 1996-10-23
Abstract: Compositions and methods for using CTLA-8 to treat an abnormal physiological condition in an individual. The methods comprise administering a therapeutically effective amount of CTLA-8 alone, or in combination with other therapeutic reagents; or a CTLA-8 antagonist.
Patent AU-7498087-A (AU)
Title: Biological information measurement apparatus
Inventor: YAMAGUCHI SHUICHIRO
IPC: G01N33/487
Filed: 1987-06-30
Abstract: A biological information measurement apparatus is adapted to measure biological information in an extracorporeal circuration or in a living body by various measurement circuits comprising circuit elements which are not affected by electrical disturbances, and to transmit the results of measurement in the form of a non-electrical signal which is not affected by electrical disturbances. Measured values from measurement sections are gathered at a central processing section separated from the measurement sections. The processing section converts the measured values into output values, compensates the values for temperature and outputs the values to a display unit and recorder.
Patent AU-7623298-A (AU)
Title: Device for local administration of solid and semisolid formulations, sustained-release formulations for parenteral administration and method of preparation
Inventor: CHERIF-CHEIKH ROLAND
IPC: A61K9/70
Filed: 1997-12-02
Abstract: The use of a specific device is claimed for implantation or insertion of a solid or semi-solid formulation (F), containing an active ingredient (A), into an organism at a precise receptor site. The device includes a component which is inserted into the body of the patient, can store (F) and can position (F) the precise site where it is required. The injection or insertion of (F) can be controlled externally. The device is withdrawn after (A) has been so placed. Formulations for use in the device are also claimed, specifically containing at least 50% of (A) mixed with a polylactide-glycolide copolymer (PGLA).
Patent AU-7623696-A (AU)
Title: Communication system with base station transceiver and radio communication units
Inventor: BENN HOWARD
IPC: H04W88/08
Filed: 1996-11-13
Abstract: Signal processing for multiple Radio Frequency (RF) heads (162-172) of a communication system (160) is located at a central control unit (158), such as a base station transceiver. More particularly, in the case where the RF head requires transmission and reception capabilities (in a TDM pico-cellular environment, for example), the central control unit is arranged to undertake power intensive channel coding and channel decoding for each of the RF heads, while the RF heads principally contain RF circuitry required for communication. As such, power consumption and heat generation arising from signal processing is restricted to the central control unit (158), thereby allowing a reduction in the cost and physical size of the RF heads (162-172).
Patent AU-7754894-A (AU)
Title: Cryogenic heat exchange system and freeze dryer
Inventor: LEE RON C
IPC: F25D3/10
Filed: 1994-10-28
Abstract: A cryogenic heat exchange system with particular application to a freeze dryer comprising a heat exchanger having at least one pass for receiving a cryogenic heat exchange fluid; a reversing circuit connected to the at least one pass having an inlet for receiving the cryogenic heat exchange fluid, means for introducing the cryogenic heat transfer fluid into the at least one pass and for reversing flow direction of the cryogenic heat transfer fluid so that the cryogenic heat exchange fluid flows through the at least one pass in one flow direction and then in an opposite flow direction, and an outlet for receiving a portion of the cryogenic heat transfer fluid from the at least one pass after having passed therethrough as spent cryogenic heat exchange fluid; recirculation means connected to the outlet of the reversing circuit for receiving the spent cryogenic heat transfer fluid and having a mixing chamber for mixing the spent cryogenic heat transfer fluid with a cryogen, to form the cryogenic heat exchange fluid and thereby to increase the enthalpy of the cryogenic heat transfer fluid over that of the cryogen, a mixing chamber outlet in communication with the inlet to the reversing circuit for introducing the cryogenic heat transfer fluid into the reversing circuit, and means for circulating the cryogenic heat transfer fluid to the reversing circuit, through the at least one pass and back to the mixing chamber as the spent cryogenic heat exchange fluid; and vent means for venting a remaining portion of the cryogenic heat transfer fluid after having passed through the at least one pass of the at least one heat exchanger. <IMAGE>
Patent AU-7953794-A (AU)
Title: Formulations for delivery of osteogenic proteins
Inventor: YIM KALVIN W K
IPC: A61L27/22
Filed: 1994-09-02
Abstract: A composition is disclosed comprising a pharmaceutically acceptable admixture of an osteogenic protein; a porous particulate polymer matrix; an osteogenic protein-sequestering amount of blood clot; and a calcium sulfate hemihydrate-containing substance. Also disclosed are formulations of bone morphogenetic proteins with improved solubility and/or stability characteristics.
Patent AU-7997900-A (AU)
Title: Percutaneous stent graft and method for vascular bypass
Inventor: FAN CHIEH-MIN
IPC: A61F2/82
Filed: 2000-10-06
Abstract: A prosthetic vessel graft assembly has a tube of synthetic graft material surrounding a stent at its distal end, together with a plurality of collapsible anchors projecting radially from the stent. The assembly mounts on an introducer that may be tunneled through skin or inserted in an opening and pushed down to a vessel for introducing the graft through the vessel side wall. The introducer is configured to follow a guide wire which is inserted via a needle through an opening in the side wall of the vessel. A peel-away sheath covers the stent, graft, and anchor members at the distal end keeping them collapsed against the tubular body.
Patent AU-8141991-A (AU)
Title: Substituted sulfonamides, process of preparation and medicines containing same
Inventor: LARDY CLAUDE
IPC: C07D233/54
Filed: 1991-07-29
Abstract: New substituted sulphonamides, their salts, complexes, esters and amides which are physiologically acceptable, denoted by the formula <IMAGE>  in which:   R1 is an aryl radical or a heterocyclic ring, optionally (poly)substituted; R2 and R3 are different; one of the two denotes W, the other is hydrogen, halogen, trifluoromethyl, alkyl, cycloalkyl, alkoxy, alkylthio, alkylsulphinyl, alkylsulphonyl, acyl, thioacyl, hydroxyl, optionally (poly)substituted amine, nitro, nitrile, azide or aryl; W is a -Z-Ar-(CH2)q-A group in which A is CO2H or a group capable of being hydrolysed to CO2H, SO3H, PO3H, a heterocyclic ring, an acyl radical, an oxoalkylcarboxylic radical or a primary alcohol; q is 0,1,2,3 or 4; Ar is an aryl radical or an aromatic heterocyclic ring, optionally substituted by a radical R7; Z is oxygen, CH2 or a bond; R4-7 take simultaneously or independently the values of R2-3, except W; Y is a -(CH2)s-B-(CH2)t- group; s and t are 0,1 or 2; B is an oxygen atom, oxidised or unoxidised sulphur, optionally substituted nitrogen, a (thio)carbonyl functional group, a heterocyclic ring, an alkylene radical, an optionally substituted alkyl radical or a bond;   n is 0 or 1.   Application of these thromboxane A2 receptor antagonist compounds with a long period of activity as antithrombotic and antiasthmatic medications.